News

The agreement permits Barr and Teva to launch generic versions of these Xopenex inhalation solution dosages under terms of a non-exclusive license commencing on February 17, 2013. The

IDM Pharma, a biopharmaceutical company, has announced that the European Commission has formally granted a centralized marketing authorization for Mepact for the treatment of patients with non-metastatic, resectable

Endologix, a developer of minimally invasive therapies for the treatment of vascular disease, has received the FDA approval of the IntuiTrak express delivery system for the Powerlink XL

Switzerland-based pharmaceutical company Synosia Therapeutics has entered into a second agreement with Roche, pursuant to which, Synosia gains access to a new-generation 5-HT6 antagonist in Phase I to

This contract allows any branch of the Department of Defense, Veterans Administration Medical Centers or government agencies to purchase directly from Swissray. With exercisable option years the contract

Mr Rosen will continue in his position with Fresenius Medical Care for the time necessary to ensure a smooth transition of the CFO responsibilities. Mr Rosen has been

Human Genome Sciences, a biopharmaceutical company, has announced that Albuferon met its primary endpoint of non-inferiority to peginterferon alfa-2a in Achieve 1, a Phase III clinical trial of

Under the contract, LCA will place Allegretto Wave Eye-Q 400Hz excimer lasers in all of the company’s 75 LasikPlus vision surgery centers by the end of the third

The European Commission decision, based on a favorable opinion from the European Medicines Agency, follows the designation of KNS-760704 as an orphan drug for the treatment of amyotrophic